Johannes Lemke

2.8k total citations
43 papers, 1.8k citations indexed

About

Johannes Lemke is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Johannes Lemke has authored 43 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Johannes Lemke's work include Pancreatic and Hepatic Oncology Research (13 papers), Cell death mechanisms and regulation (10 papers) and Cancer-related Molecular Pathways (7 papers). Johannes Lemke is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Cell death mechanisms and regulation (10 papers) and Cancer-related Molecular Pathways (7 papers). Johannes Lemke collaborates with scholars based in Germany, United Kingdom and Hungary. Johannes Lemke's co-authors include Henning Walczak, Silvia von Karstedt, Doris Henne‐Bruns, Julia Zinngrebe, Diego de Miguel, Luis Martínez‐Lostao, Alberto Anel, Anna-Laura Kretz, Marko Kornmann and Mathias Wittau and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Johannes Lemke

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Lemke Germany 21 1.1k 658 419 284 255 43 1.8k
Yongdong Feng China 26 972 0.9× 641 1.0× 326 0.8× 397 1.4× 176 0.7× 64 1.7k
Chaoliu Dai China 17 870 0.8× 627 1.0× 363 0.9× 453 1.6× 248 1.0× 44 1.8k
Carman A. Giacomantonio Canada 23 1.1k 1.0× 935 1.4× 227 0.5× 591 2.1× 225 0.9× 46 2.2k
Hans Raskov Denmark 17 733 0.7× 973 1.5× 778 1.9× 287 1.0× 294 1.2× 32 2.0k
Xiaomei Zhang China 16 706 0.6× 768 1.2× 631 1.5× 349 1.2× 268 1.1× 36 1.9k
Yi‐Jun Wang United States 29 982 0.9× 1.6k 2.5× 646 1.5× 215 0.8× 203 0.8× 75 2.5k
Ying Hu China 22 618 0.6× 659 1.0× 337 0.8× 285 1.0× 319 1.3× 101 1.6k
Suimin Qiu United States 26 1.0k 0.9× 942 1.4× 389 0.9× 428 1.5× 234 0.9× 91 2.5k

Countries citing papers authored by Johannes Lemke

Since Specialization
Citations

This map shows the geographic impact of Johannes Lemke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Lemke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Lemke more than expected).

Fields of papers citing papers by Johannes Lemke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Lemke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Lemke. The network helps show where Johannes Lemke may publish in the future.

Co-authorship network of co-authors of Johannes Lemke

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Lemke. A scholar is included among the top collaborators of Johannes Lemke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Lemke. Johannes Lemke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kretz, Anna-Laura, Sandra M. Schneider, Uwe Knippschild, et al.. (2023). Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer. Biomedicines. 11(3). 928–928. 9 indexed citations
2.
Scheele, Jan, Johannes Lemke, Mathias Wittau, et al.. (2022). Quality of Life after Rectal Cancer Resection Comparing Anterior Resection, Abdominoperineal Resection, and Complicated Cases. Visceral Medicine. 38(2). 138–149. 4 indexed citations
3.
Kretz, Anna-Laura, et al.. (2021). The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death. Anticancer Research. 41(12). 5973–5985. 8 indexed citations
4.
Beutel, Alica K., Lena Schütte, Élodie Roger, et al.. (2021). A Prospective Feasibility Trial to Challenge Patient–Derived Pancreatic Cancer Organoids in Predicting Treatment Response. Cancers. 13(11). 2539–2539. 37 indexed citations
5.
Bartsch, F., Felix Rückert, Moritz Schmelzle, et al.. (2020). Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study. Liver International. 41(1). 180–191. 20 indexed citations
6.
Haselmann, Verena, et al.. (2019). TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors. Cancers. 11(8). 1167–1167. 15 indexed citations
7.
Wagner, Martin, et al.. (2019). Calcitonin concentrations in patients with chronic kidney disease on hemodialysis in reference to parathyroidectomy. BMC Research Notes. 12(1). 439–439. 3 indexed citations
8.
Legler, Karen, Charlotte A. E. Hauser, Jan‐Hen drik Egberts, et al.. (2018). The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells. Cell Death and Disease. 9(5). 445–445. 33 indexed citations
9.
Richter, Julia, Anna-Laura Kretz, Johannes Lemke, et al.. (2018). CK1α overexpression correlates with poor survival in colorectal cancer. BMC Cancer. 18(1). 140–140. 23 indexed citations
10.
Hillenbrand, Andreas, et al.. (2018). Postoperative swallowing disorder after thyroid and parathyroid resection. PubMed. Volume 9. 63–68. 13 indexed citations
11.
Traub, Benno, Lie Sun, Yongsu Ma, et al.. (2017). Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo. International Journal of Molecular Sciences. 18(4). 716–716. 17 indexed citations
12.
Kretz, Anna-Laura, Julia Richter, Frank Leithäuser, et al.. (2017). CDK9 is a prognostic marker and therapeutic target in pancreatic cancer. Tumor Biology. 39(2). 2901571936–2901571936. 50 indexed citations
13.
Miguel, Diego de, Johannes Lemke, Alberto Anel, Henning Walczak, & Luis Martínez‐Lostao. (2016). Onto better TRAILs for cancer treatment. Cell Death and Differentiation. 23(5). 733–747. 259 indexed citations
14.
Lemke, Johannes, Jan Scheele, Pengfei Xu, et al.. (2016). Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment. Clinical Colorectal Cancer. 15(4). e183–e192. 27 indexed citations
15.
Scheele, Jan, et al.. (2015). Quality of Life After Sphincter-Preserving Rectal Cancer Resection. Clinical Colorectal Cancer. 14(4). e33–e40. 21 indexed citations
16.
Scheele, Jan, Johannes Lemke, Thomas F.E. Barth, et al.. (2014). Chondroid hamartoma of the liver. SHILAP Revista de lepidopterología. 3. Doc16–Doc16. 1 indexed citations
17.
Lemke, Johannes, Silvia von Karstedt, Julia Zinngrebe, & Henning Walczak. (2014). Getting TRAIL back on track for cancer therapy. Cell Death and Differentiation. 21(9). 1350–1364. 381 indexed citations
18.
Lemke, Johannes, Silvia von Karstedt, Annalisa Conti, et al.. (2013). Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1. Cell Death and Differentiation. 21(3). 491–502. 107 indexed citations
19.
Heise, Daniel, Torben Redmer, Freya A. Goumas, et al.. (2011). Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti‐inflammatory activities in pancreatic tumor cells. Cancer Science. 102(4). 728–734. 90 indexed citations
20.
Lemke, Johannes, Andreas Noack, Dieter Adam, et al.. (2010). TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5. Journal of Molecular Medicine. 88(7). 729–740. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongdong Feng Breakdown of academic impact, for papers by Chaoliu Dai Breakdown of academic impact, for papers by Carman A. Giacomantonio Breakdown of academic impact, for papers by Hans Raskov Breakdown of academic impact, for papers by Xiaomei Zhang Breakdown of academic impact, for papers by Yi‐Jun Wang Breakdown of academic impact, for papers by Ying Hu Breakdown of academic impact, for papers by Suimin Qiu
Rankless by CCL
2026